Adial Pharmaceuticals, Inc.
- ADIL
- NASDAQ
- Biotechnology
- Addiction Therapeutics
- Clinical-Stage Biopharma
$3.49
Today +11.15%Quote Oct 16, 2026, 08:00 PM UTC
−33.01%over the last month
Max drawdown −42.4%From 1-month high −33.0%3 months +27.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$9.2M
Quote Oct 16
Next earnings
Nov 18
Expected, not confirmed
Analyst target
$8.50
+143.6% from here
Floor
$3.10
11.2% below price
Where the price sits
3 analysts
Analyst range, low to high
$6.00$11.00
- Price $3.49
- Resistance $3.50
- Consensus $8.50
The price is right under resistance. Analysts' average target sits about 144% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about ADILPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
5